ADAPTIMMUNE THERAPEUTICS-ADR (ADAPY:OTCMKTS)
$0.015 0.005 (50%)
Analysed ADAPTIMMUNE THERAPEUTICS-ADR (ADAPY:OTCMKTS) News Sources
Flagship Pioneering Appoints Adrian Rawcliffe as CEO-Partner and CEO of Etiome
08-01-2026
yahoo.com
Adaptimmune Announces Changes to Board and Executive Leadership Team
17-11-2025
yahoo.com
What is the current price of ADAPTIMMUNE THERAPEUTICS-ADR (ADAPY:OTCMKTS)?
The current price of ADAPTIMMUNE THERAPEUTICS-ADR (ADAPY:OTCMKTS) is $0.015.
ADAPTIMMUNE THERAPEUTICS-ADR (ADAPY:OTCMKTS) absolute price change since previous trading day?
The absolute price change of ADAPTIMMUNE THERAPEUTICS-ADR (ADAPY:OTCMKTS) since the previous trading day is $0.005.
ADAPTIMMUNE THERAPEUTICS-ADR (ADAPY:OTCMKTS) percentage price change since previous trading day?
The percentage price change of ADAPTIMMUNE THERAPEUTICS-ADR (ADAPY:OTCMKTS) since the previous trading day is 50%.
What is the most recent average sentiment score for ADAPTIMMUNE THERAPEUTICS-ADR (ADAPY:OTCMKTS)?
The most recent average sentiment score for ADAPTIMMUNE THERAPEUTICS-ADR (ADAPY:OTCMKTS) is 83 out of 100.
What is the most recent average sentiment for ADAPTIMMUNE THERAPEUTICS-ADR (ADAPY:OTCMKTS)?
The most recent sentiment for ADAPTIMMUNE THERAPEUTICS-ADR (ADAPY:OTCMKTS) is .
SEC-8K** Filing Available For ADAPTIMMUNE THERAPEUTICS-ADR (ADAPY:OTCMKTS)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.